BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

4.91
Delayed Data
As of 4:00pm ET
 +0.07 / +1.45%
Today’s Change
3.95
Today|||52-Week Range
7.39
0.00%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close4.84
Today’s open4.81
Day’s range4.76 - 5.04
Volume542,107
Average volume (3 months)1,141,285
Market cap$549.1M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-4.00%
Earnings growth (this year)-6.96%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-4.43%
P/E ratioNM
Price/Sales16.46
Price/Book6.56

Competitors

 Today’s
change
Today’s
% change
MRSNMersana Therapeutics...-0.17-1.01%
CYADCelyad SA-0.20-0.63%
SELBSelecta Biosciences ...-0.05-0.40%
NSTGNanoString Technolog...-0.27-2.83%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$25.2M
Annual profit (last year)-$65.8M
Net profit margin-261.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts